Drug Eluting Balloon Market, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Eur

Drug Eluting Balloon Market, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe. Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels. They also have been investigated in clinical trials to prevent coronary artery in-stent restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia (scar tissue growth) caused by trauma when the vessel segment is treated for atherosclerotic lesions with balloon angioplasty. DCBs can be used to treat hyperplasia in arteriovenous (AV) access fistulae in dialysis patients, where the vessel undergoes repeated trauma from regular punctures. DCBs are also used to treat in-stent restenosis due to scar tissue proliferation inside stents, which can cause a vessel to occlude. Angioplasty using percutaneous coronary intervention techniques revealed satisfying result compared to conservative medical treatment.

Market Dynamics

Increasing product launches by key players in market are expected to drive the global drug eluting balloon market growth. For instance, in October 2019, Koninklijke Philips N.V., a health technology company, launched two new Stellarex Drug-Coated Balloon Sizes. Royal Philips introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035” low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. The new balloons broadened physicians’ treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis and expand the Stellarex portfolio.

Key features of the study:

  • This report provides an in-depth analysis of the global drug eluting balloon market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global drug eluting balloon market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global drug eluting balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting balloon market
Detailed Segmentation:
  • Global Drug Eluting Balloon Market, By Product Type:
  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon
  • Others
  • Global Drug Eluting Balloon Market, By End User:
  • Hospitals
  • CATH Laboratories
  • Ambulatory Surgical Centres
  • Others
  • Global Drug Eluting Balloon Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Medtronic *
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical
  • Braun Melsungen AG
  • Koninklijke Philips N.V.
  • Opto Circuits (India) Limited
  • Terumo Corporation
  • Surmodics, Inc.
  • Biotronik
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Impact Analysis
Key Highlights
PEST Analysis
PORTER’s Analysis
Mergers and Acquisitions
Epidemiology
4. Global Drug Eluting Balloon Market- Impact of Coronavirus (Covid-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Drug Eluting Balloon Market, By Product Type, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Coronary Drug Eluting Balloon
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Peripheral Drug Eluting Balloon
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Drug Eluting Balloon Market, By End User, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
CATH Laboratories
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Ambulatory Surgery Centers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
7. Global Drug Eluting Balloon Market, By Region, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Medtronic
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Becton, Dickinson and Company
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Boston Scientific Corporation
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Cook Medical
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
B. Braun Melsungen AG
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Koninklijke Philips N.V.
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Opto Circuits (India) Limited
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Terumo Corporation
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Surmodics, Inc.
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Biotronik
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
Research Methodology
About Us
*Browse 35 market data tables and 28 figures on "Global Drug Eluting Balloon Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings